meglumine antimoniate has been researched along with Acute Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Layegh, P; Mashayekhi Goyonlo, V; Morovatdar, N; Nahidi, Y; Tafazzoli, Z | 1 |
| Layegh, P; Mashayekhi Goyonlo, V; Nahidi, Y; Najaf Najafi, M; Taghavi, F | 1 |
| Hashemzadeh, S; Khoddami, M; Layegh, P; Rajabi, O | 1 |
| Arasteh, M; Babakoohi, S; Firooz, A; Kashani, MN; Nilforoushzadeh, MA; Sadr, B | 1 |
| Asilian, A; Iraji, F; Momeni, AZ; Shahtalebi, MA; Vali, A | 1 |
| Aste, G; Boari, A; Di Tommaso, M; Steiner, JM; Williams, DA | 1 |
| Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| Barthet, M; Berland, Y; Bernard, JC; Brunet, P; Dussol, B; Jouglard, J; Rodor, F; Sahel, J | 1 |
| de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M | 1 |
| Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D | 1 |
| González Lahoz, J; Laguna, F; Valencia, ME | 1 |
| Márquez, M; Rivero, A; Santos, J | 1 |
| Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T | 1 |
| Almeida, RP; Badaró, F; Badaró, R; Barral, A; Barral-Netto, M; Carvalho, EM; Falcoff, E; Falcoff, R; Pedral-Sampaio, D; Santos, SB | 1 |
1 review(s) available for meglumine antimoniate and Acute Disease
| Article | Year |
|---|---|
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous | 2000 |
5 trial(s) available for meglumine antimoniate and Acute Disease
| Article | Year |
|---|---|
Evaluating the efficacy and safety of vascular IPL for treatment of acute cutaneous leishmaniasis: a randomized controlled trial.
Topics: Acute Disease; Adult; Antiprotozoal Agents; Case-Control Studies; Female; Humans; Injections, Intralesional; Intense Pulsed Light Therapy; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Treatment Outcome | 2021 |
Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Pilot Projects; Treatment Outcome; Young Adult | 2021 |
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Cutaneous; Adolescent; Adult; Antiprotozoal Agents; Azithromycin; Child; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Young Adult | 2016 |
Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun.
Topics: Acute Disease; Adolescent; Adult; Child; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesotherapy; Organometallic Compounds; Pain; Treatment Outcome; Young Adult | 2010 |
Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiprotozoal Agents; Case-Control Studies; Child; Child, Preschool; Double-Blind Method; Female; Humans; Injections, Intralesional; Injections, Subcutaneous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Sulfate | 2004 |
8 other study(ies) available for meglumine antimoniate and Acute Disease
| Article | Year |
|---|---|
Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2005 |
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence | 1995 |
[Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
Topics: Acute Disease; Adult; Animals; Antiprotozoal Agents; Female; Humans; Immune Tolerance; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1994 |
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1993 |
Meglumine antimoniate-induced pancreatitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1996 |
[Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis | 2000 |
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2001 |
Tumor necrosis factor (cachectin) in human visceral leishmaniasis.
Topics: Acute Disease; Antimony; Antiprotozoal Agents; Cells, Cultured; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |